Women's Health–

Women's Health Clinical Studies

Women’s Health at Stanford, a multidisciplinary program in the Stanford University School of Medicine, is actively engaged in supporting a variety of research efforts, including clinical studies of conditions and treatments relevant to women.Consent
              
For women potentially interested in participating in a clinical study at Stanford University Medical Center, we offer the following links to related information:


WOMEN'S CANCERS

Combined Treatment for Advanced Stage Ovarian Cancer (more)
Interleukin-18 (IL-18) is an investigational agent that may enhance the anti-tumor activity of Doxil® by stimulating the immune response. Dr. Jonathan Berek and colleagues are enrolling patients in this Phase I clinical research study to identify a dose of IL-18 which is safe and tolerable and provides maximum biological effect. The dose selected from this study will be used in a future study evaluating the efficacy of the IL-18/ Doxil® combination in women with advanced ovarian cancer.

Monoclonal Antibody Vaccination to Prevent or Delay Ovarian Cancer Recurrence (“MIMOSA” Study) (more)
The current approach to ovarian cancer remission after successful surgery and chemotherapy is “watch and wait”.  The purpose of this study is to evaluate whether Abagovomab can be used as a vaccine to safely prevent or delay tumor regrowth.

Healing Touch during Chemotherapy Infusions for Women with Breast Cancer (more)
Healing Touch (HT) is a non-invasive form of energy-balancing work in which the provider gently places their hands slightly above or on the recipient who is reclining or lying down fully clothed.  This study tests the effectiveness of HT provided during chemotherapy infusions on improving quality of life in women undergoing treatment for breast cancer by comparing it to a form of guided relaxation and standard of care.

Other women’s cancers studies can be viewed by clicking on these links:

WOMEN'S HEART HEALTH

Sex Differences in Heart Disease (more)
A significant portion of patients with symptoms of heart problems go undiagnosed and untreated because their arteries look normal on traditional tests.  This study is examining whether women with chest pain, but normal-looking heart angiogram, are more likely than men with similar symptoms to have certain types of heart dysfunction. More information


FAMILY PLANNING

Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy
Misoprostol is commonly used off-label to induce labor after fetal death. The purpose of this study is to demonstrate that misoprostol has high safety and effectiveness as well as help establish the best dose of misoprostol for this purpose. 


FERTILITY AND REPRODUCTIVE MEDICINE

Progesterone Support in IVF Treatment
Progesterone is the natural hormone that a woman's body produces to support the uterine lining and maintain an early pregnancy. It has been shown that progesterone supplementation increases the chance of success with IVF. Dr. Valerie Baker and colleagues are enrolling women in a clinical research study to evaluate the safety and effectiveness of a new, investigational progesterone formulation delivered by subcutaneous injection (Progesterone- IBSA), as compared to an FDA-approved vaginal preparation (Endometrin®).

REI Clinical Database and Serum Banking Project
The purpose of this research is to study reproductive disorders and their treatments.  Consented leftover serum will be used for analyzing diagnostic tests for reproductive disorders.  Patients must be undergoing IVF treatment at the Stanford Fertility and Reproductive Medicine Center to participate. 

Day 2 versus Day 3 Embryo Transfer(more)
The purpose of this research is to examine whether pregnancy rates differ among patients with a limited number of available embryos based on the day of embryo transfer (Day 2 vs. Day 3). Patients must be undergoing IVF treatment at the Stanford Fertility and Reproductive Medicine Center to participate. 


STEM CELLS AND REGENERATIVE MEDICINE

Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability (more)
In this study, underarm skin biopsies are collected from patients with conditions including infertility, diabetes, Parkinson’s, heart disease and ALS. Somatic cell nuclear transfer (SCNT) and/or genetic reprogramming research using the collected tissue may result in the production of disease-specific human embryonic stem cell lines (hESC) that may be used to create new therapies in future studies. 

Egg Donation for Human Cell Reprogramming
The purpose of this research is to increase basic knowledge regarding human development of eggs and human cell reprogramming, and potentially to develop novel stem cell based therapies for human diseases.  Donated eggs will not be used for reproductive purposes.


UROGYNECOLOGY

Bulking Agents for the Treatment of Stress Urinary Incontinence in Females
Stress urinary incontinence (SUI) is an involuntary leakage of urine that occurs during physical activity, such as coughing, sneezing, laughing, or exercise.  This study is designed to compare the effectiveness and safety of two bulking agents in the treatment of SUI.

Efficacy Study of Vaginal Mesh for Prolapse (“VAMP” Study)
20-30% of traditional surgeries to correct vaginal prolapse (bulging of slipped organs into the vaginal wall) will eventually fail.  This study is testing whether the addition of a synthetic mesh support improves the long-term success of surgical repair.


MATERNAL FETAL MEDICINE

Pain Study of Rectus Muscles Closure at Cesarean Delivery
The purpose of this study is to assess the effect of rectus muscle reapproximation at cesarean delivery and post-operative pain. This study will also assess the impact of rectus muscle closure on adhesions as seen at repeat cesarean delivery.

To view the Women's Health Certified Clinical Research Coordinator's

 

Women’s Health at Stanford general contact information:

 

back to Women’s Health at Stanford home page

Stanford Medicine Resources:

Footer Links: